Trial intelligence / Profile preview

GIPS-IV: Sodium thiosulfate after STEMI

2015-001006-34Phase 2Active

Sponsor
University Medical Center Groningen
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in myocardial infarction (MI) and heart failure (HF) comparing Sodium thiosulfate arm with Placebo arm (2 arms). Primary endpoint: Myocardial infarct size at 4 months. Started Jul 2016; status: active.

02

Drugs

sodium thiosulfate
03

Conditions

myocardial infarction (MI)heart failure (HF)

Beyond the preview

Go deeper on 2015-001006-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001006-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call